PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | |hepatocellular carcinoma |
| Sentences | 268 |
| PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
| PubMedID- 23844083 | Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection. |
| PubMedID- 23044807 | Association of xrcc1, xrcc3, and xpd genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis b and c virus. |
| PubMedID- 24023999 | A 49 year-old woman (160.0 cm, 94.6 kg) suffering from hepatocellular carcinoma with end-stage hepatitis b liver cirrhosis (model for end stage liver disease [meld] score 14, child-pugh class b) presented for living donor lt. she had hypertension that was well controlled with medications. |
| PubMedID- 20738778 | Increased pd-1 and decreased cd28 expression in chronic hepatitis b patients with advanced hepatocellular carcinoma. |
| PubMedID- 25544880 | Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri. |
| PubMedID- 22875473 | Inhibition of hepatocellular carcinoma by pegifnalpha-2a in patients with chronic hepatitis c: a nationwide multicenter cooperative study. |
| PubMedID- 25312649 | The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 25945007 | Aim: to clarify the utility of using des-gamma-carboxy prothrombin (dcp) and alpha-fetoprotein (afp) levels to predict the prognosis of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) and the hepatitis c virus (hcv) infections. |
| PubMedID- 24223741 | Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir). |
| PubMedID- 20087166 | hepatitis c prevalence in patients with hepatocellular carcinoma without cirrhosis. |
| PubMedID- 23098451 | Why is hepatocellular carcinoma less attributable to viral hepatitis in yemen. |
| PubMedID- 25894298 | Aflatoxin levels in chronic hepatitis b patients with cirrhosis or hepatocellular carcinoma in balikesir, turkey. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 22066022 | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. |
| PubMedID- 24693297 | Transient elastography has also been used to assess the degree of liver fibrosis and the risk of hepatocellular carcinoma development in patients with chronic hepatitis (56, 57). |
| PubMedID- 21610221 | Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis. |